Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | May 9, 2016 |
| Target | Expedeon Holdings |
| Sector | Life Science |
| Buyer(s) | 4basebio |
| Deal Type | Add-on Acquisition |
FILTER BY
| Category | Company |
|---|---|
| Founded | 2008 |
| Sector | Life Science |
| Employees | 110 |
| Revenue | 1M GBP (2023) |
4basebio is a development of novel, superior tools for molecular biology that play key roles in changing the way genomic and proteomic research is done today. Demand for such tools is high in the fast-growing DNA and protein analysis markets. SYGNIS’ polymerases enable a wide range of applications for DNA amplification, repair, sequencing, detection, and modification of genetic targets of clinical value. The company is thus ideally suited to play a major part in the global effort to discover the genetic markers of disease, and their cost-effective detection, in individual patients to deliver optimized treatments. 4basebio was founded in 2008 and is headquartered in Cambridge, England.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Add-on Acquisition | 1 of 1 |
| Country: United Kingdom | 1 of 1 |
| Year: 2016 | 1 of 1 |
